heartbeat medical is a technology company.
heartbeat medical has raised $10.0M across 2 funding rounds.
heartbeat medical has raised $10.0M in total across 2 funding rounds.
Heartbeat Medical is a Berlin- and London-based digital health company founded in 2014 that provides a platform for collecting, analyzing, and utilizing Patient-Reported Outcomes (PROs) to measure treatment impacts on patients' quality of life.[1][2][4] It serves over 200 hospitals, medical registries, and research projects across Europe, supporting more than 350,000 patients by enabling healthcare providers, payers, pharmaceutical companies, and device makers to ensure treatments meet patient expectations, regulatory standards, and reimbursement needs.[2][4] The platform simplifies PRO data collection for clinical practice, research, and market approvals, positioning Heartbeat Medical as Germany's leading PRO provider with strong growth in hospital chains and university settings.[2][4]
(Note: Search results distinguish this from U.S.-based Heartbeat Health, a separate virtual-first cardiology platform serving over one million patients nationwide; this profile focuses on Heartbeat Medical as specified in the query.)[3][5][6]
Heartbeat Medical was founded in 2014 in Germany, emerging as a response to the need for efficient, sustainable PRO data collection in healthcare.[2][4] The company's backstory centers on supporting transformative projects for leading organizations, starting with hospital chains and university hospitals to gather data across diverse disease areas.[4] Early traction came from enabling over 100,000 patients' data collection, expanding to a network spanning Berlin and London, and partnering with 200+ entities for research and clinical outcomes monitoring.[2][4] Pivotal moments include powering leading research projects, generating evidence for drug evaluations in regulatory procedures, and scaling to 350,000+ patients, solidifying its role in European digital health.[2]
Heartbeat Medical rides the wave of value-based healthcare and real-world evidence (RWE) trends, where PROs are increasingly vital for proving treatment efficacy amid rising regulatory demands from bodies like the EMA.[1][2] Timing is ideal as Europe's healthcare systems prioritize patient-centric metrics for reimbursement and outcomes-based payments, amplified by post-pandemic digital health adoption.[2] Market forces like aging populations, chronic disease burdens, and pharma's need for RWE favor its growth, influencing the ecosystem by standardizing PROs—bridging clinical practice, research, and policy to elevate quality-of-life metrics in decision-making.[1][2][4]
Heartbeat Medical is poised for expanded European dominance in PRO analytics, potentially growing its patient base beyond 350,000 through deeper pharma and payer integrations.[2] Trends like AI-enhanced PRO insights and cross-border data harmonization will shape its trajectory, enabling real-time quality-of-life benchmarking.[1] Its influence may evolve toward global standards, powering next-gen therapies while reinforcing patient voices as central to healthcare innovation—echoing its mission to make quality of life the driver of better care.[1]
heartbeat medical has raised $10.0M in total across 2 funding rounds.
heartbeat medical's investors include Angel Invest, DST Global, HV Capital, Kima Ventures, Lakestar, mExpand Family Office, Zeev Capital, Eric Nadalin, Tony Jamous, Will Brooks, Will Martin.
heartbeat medical has raised $10.0M across 2 funding rounds. Most recently, it raised $6.0M Series A in October 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 1, 2020 | $6.0M Series A | Angel Invest, DST Global, HV Capital, Kima Ventures, Lakestar, mExpand Family Office, Zeev Capital, Eric Nadalin, Tony Jamous, Will Brooks, Will Martin | |
| Dec 1, 2017 | $4.0M Venture Round | HV Capital |